000

THERAGEN ETEX

No trades
See on Supercharts
Market capitalization
‪125.46 B‬KRW
‪26.21 B‬KRW
‪221.72 B‬KRW
‪25.86 M‬
Beta (1Y)
0.75

About THERAGEN ETEX

Headquarters
Ansan-si
Employees (FY)
209
Founded
1990
ISIN
KR7066700006
FIGI
BBG000PGJ595
THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products and in the provision of genome sequencing services. It operates through the following business divisions: Pharmaceutical, Specialized drug distribution, Healthcare and Genome. It offers cimetidine tabs, dimetal tabs, gabamin tabs, aclfen tab, hydone tab, other pharmaceutical products and genome analysis services. The company was founded on September 27, 1990 and is headquartered in Ansan-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 066700 is 3915 KRW — it has decreased by 0.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange THERAGEN ETEX stocks are traded under the ticker 066700.
066700 stock is 1.03% volatile and has beta coefficient of 0.75. Check out the list of the most volatile stocks — is THERAGEN ETEX there?
Yes, you can track THERAGEN ETEX financials in yearly and quarterly reports right on TradingView.
066700 stock hasn't changed in a week, the month change is a 13.10% fall, over the last year THERAGEN ETEX has showed a 29.96% decrease.
066700 net income for the last quarter is ‪20.87 B‬ KRW, while the quarter before that showed ‪3.54 B‬ KRW of net income which accounts for 490.20% change. Track more THERAGEN ETEX financial stats to get the full picture.
Today THERAGEN ETEX has the market capitalization of ‪125.30 B‬, it has increased by 2.23% over the last week.
No, 066700 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 066700 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERAGEN ETEX stock right from TradingView charts — choose your broker and connect to your account.
066700 reached its all-time high on Apr 27, 2018 with the price of 22500 KRW, and its all-time low was 890 KRW and was reached on Oct 28, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 209.00 employees. See our rating of the largest employees — is THERAGEN ETEX on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THERAGEN ETEX technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THERAGEN ETEX stock shows the sell signal. See more of THERAGEN ETEX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERAGEN ETEX EBITDA is ‪17.09 B‬ KRW, and current EBITDA margin is 7.98%. See more stats in THERAGEN ETEX financial statements.